A Novel Liver-targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men With Prostate Cancer.

J Endocr Soc · 2021 · PMC8294688 · PMID 34308090

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was a trend toward a greater loss of LBM in the acute group during placebo treatment [−0.59 (−1.6 to 0.41) vs −0.04 (−0.83 to 0.75) kg chronic] and lesser gains in LBM during LTTT [0.38 (−0.61 to 1.37) vs 0.68 (−0.26 to 1.62) kg], although the differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.